Nvolve, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Nvolve, Inc. - overview

Established

2017

Location

Winston-Salem, NC, US

Primary Industry

Medical Devices & Equipment

About

Nvolve, Inc. is a US-based company that specializes in providing innovative patient engagement solutions geared towards enhancing healthcare delivery and operational efficiency. Founded in 2017 and headquartered in Winston-Salem, US, Nvolve, Inc. delivers specialized healthcare solutions.


The CEO is Thomas Frosheiser. In January 2023, CoachCare acquired Nvolve, Inc. , although financial terms were not disclosed. The company has completed a total of 4 deals, with the most recent deal occurring on January 26, 2023.


Nvolve has raised a total of USD 0. 30 mn in its latest funding round. Nvolve, Inc. focuses on developing patient engagement solutions aimed at improving healthcare delivery.


Their core offerings empower healthcare providers with tools that enhance patient interaction and support operational efficiency. By integrating seamlessly into existing systems, these solutions aim to improve patient outcomes and engagement metrics. Nvolve, Inc. operates a revenue model based on service subscriptions, allowing healthcare providers to utilize their patient engagement solutions.


This includes contractual agreements with initial setup fees and ongoing subscription payments, which can scale as additional services are adopted. Their revenue strategy may involve collaborations with healthcare organizations to enhance service offerings and reimbursement revenues. With the backing of their recent acquisition by CoachCare in January 2023, Nvolve, Inc. plans to expand its product offerings and enhance its market footprint.


The company is focused on launching new patient engagement features designed to further improve healthcare delivery by the end of 2023. Additionally, there are intentions to enter new geographical markets, targeting regions such as Canada and parts of Europe by mid-2024, utilizing the resources from their recent funding round to support these initiatives.


Current Investors

Primary Industry

Medical Devices & Equipment

Sub Industries

Monitoring Equipment

Website

www.nvolve.com

Verticals

Wearables & Quantified Self

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.